Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Simonetta Verdiani is active.

Publication


Featured researches published by Simonetta Verdiani.


Immunity | 1995

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

Nicolai Wagtmann; Roberto Biassoni; Claudia Cantoni; Simonetta Verdiani; Mauro S. Malnati; Massimo Vitale; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta; Eric O. Long

Recognition of major histocompatibility class I molecules on target cells by natural killer (NK) cells confers selective protection from NK-mediated lysis. Cross-linking of the p58 NK receptor, involved in the recognition of HLA-C alleles, delivers a negative signal that prevents target cell lysis. Molecular cloning of the p58 NK receptor reported here revealed a new member of the immunoglobulin superfamily. Five distinct p58 receptors, with sequence diversity in the immunoglobulin-related domains, were identified in a single individual. All NK clones tested expressed at least one p58 member. Three different types of transmembrane and cytoplasmic domains exist, even among receptors with closely related extracellular domains. These data revealed a repertoire of NK cells with clonally distributed p58 receptors exhibiting diversity in both extracellular and intracellular domains.


European Journal of Immunology | 1998

p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily

Claudia Cantoni; Simonetta Verdiani; Michela Falco; Anna Pessino; Michele Cilli; Romana Conte; Daniela Pende; Marco Ponte; Mikael S. Mikaelsson; Lorenzo Moretta; Roberto Biassoni

NK cells display several killer inhibitory receptors (KIR) specific for different alleles of MHC class I molecules. A family of KIR are represented by type I transmembrane proteins belonging to the immunoglobulin superfamily (Ig‐SF). Besides cDNA encoding for these KIR, additional cDNA have been identified which encode for Ig‐SF receptors with still undefined specificity. Here we analyze one of these cDNA, termed cl.15.212, which encodes a type I transmembrane protein characterized by two extracellular Ig‐like domains and a 115‐amino acid cytoplasmic tail containing a single immuno‐receptor tyrosine‐based inhibitory motif (ITIM) which is typical of KIR. cl.15.212 cDNA displays approximately 50 % sequence homology with other Ig‐SF members. Different from the other KIR, cl.15.212 mRNA is expressed by all NK cells and by a fraction of KIR+ T cell clones. cl.15.212 cDNA codes for a membrane‐bound receptor displaying an apparent molecular mass of 49 kDa, thus termed p49. To determine the specificity of the cl.15.212‐encoded receptor, we generated soluble fusion proteins consisting of the ectodomain of p49 and the Fc portion of human IgG1. Soluble molecules bound efficiently to 221 cells transfected with HLA‐G1, ‐A3, ‐B46 alleles and weakly to ‐B7 allele. On the other hand, they did not bind to 221 cells either untransfected or transfected with HLA‐A2, ‐B51, ‐Cw3 or ‐Cw4. The binding specificity of soluble p49‐Fc was confirmed by competition experiments using an anti‐HLA class I‐specific monoclonal antibody. Finally, different cDNA encoding for molecules homologous to cl.15.212 cDNA have been isolated, two of which lack the sequence encoding the transmembrane portion, thus suggesting they may encode soluble molecules.


European Journal of Immunology | 1998

p49, a putative HLA classs I-specific inhibitory NK receptor belonging to the immunoglobulin super-family (Vol 28(6) 1998, pp 1980-1990)

Claudia Cantoni; Simonetta Verdiani; Michela Falco; Anna Pessino; M. Cilli; Romana Conte; Daniela Pende; Marco Ponte; M. S. Mikaelsson; Lorenzo Moretta; Roberto Biassoni

Page 1980 Due to a printing error the affiliation given for Michele Cilli was wrongly indicated; the correct affiliation is: Istituto Scientifico Tumori and Centro Biotecnologie Avanzate, Genova, Italy


Journal of Experimental Medicine | 1996

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Roberto Biassoni; Claudia Cantoni; Michela Falco; Simonetta Verdiani; Cristina Bottino; Massimo Vitale; Romana Conte; Alessandro Poggi; Alessandro Moretta; Lorenzo Moretta


Journal of Experimental Medicine | 1995

Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.

Roberto Biassoni; Michela Falco; A Cambiaggi; P Costa; Simonetta Verdiani; Daniela Pende; R Conte; C Di Donato; P Parham; Lorenzo Moretta


Oncogene | 1996

Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines

Raffaella Meazza; Simonetta Verdiani; Roberto Biassoni; Massimiliano Coppolecchia; Alessia Gaggero; Anna Maria Orengo; Mario P. Colombo; Bruno Azzarone; Silvano Ferrini


Journal of Experimental Medicine | 1991

In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors.

Maria Cristina Mingari; Alessandro Poggi; Roberto Biassoni; Rosanna Bellomo; Ermanno Ciccone; Nicoletta Pella; Luigia Morelli; Simonetta Verdiani; Alessandro Moretta; Lorenzo Moretta


European Journal of Immunology | 1993

Human CD3−CD16+ natural killer cells express the hGATA-3 T cell transcription factor and an unrearranged 2.3-kb TcR δ transcript

Roberto Biassoni; Simonetta Verdiani; Anna Cambiaggi; Paul-Henri Romeo; Silvano Ferrini; Lorenzo Moretta


Human Immunology | 1996

P373 - The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140 kD disulphide-linked dimer

Daniela Pende; Roberto Biassoni; Claudia Cantoni; Simonetta Verdiani; Michela Falco; Carolina Di Donato; Laura Accame; Cristina Bottino; Alessandro Moretta; Lorenzo Moretta


Human Immunology | 1996

P377 - The HLA-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

Roberto Biassoni; Claudia Cantoni; Michela Falco; Simonetta Verdiani; Cristina Bottino; Massimo Vitale; Romana Conte; Alessandro Poggi; Alessandro Moretta; Lorenzo Moretta

Collaboration


Dive into the Simonetta Verdiani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lorenzo Moretta

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Claudia Cantoni

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Michela Falco

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alessandro Poggi

National Cancer Research Institute

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge